1. AstraZeneca quits cancer pipeline efforts — Eisai's weight loss drug is pulled from market due to safety concerns — Melinta seeks buyout bids to escape bankruptcy — See more on our front page news TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

Quest Diagnostics and BioReference

Discussion in 'Quest Diagnostics' started by anonymous, Nov 15, 2019 at 9:23 AM.

  1. anonymous

    anonymous Guest

    Already in the works for certain and some say it’s a done deal. What are the implications?
     
  2. anonymous

    anonymous Guest

    Just an FYI to the folks at Bio. When Cindy tells you that Quest is definitely not buying you. Then we’re definitely buying you. Hope this helps.
     
  3. anonymous

    anonymous Guest

    Among the implications are that many Quest rejects and those that rejected Quest will be on the street.
     
  4. anonymous

    anonymous Guest

    So untrue. Quest will keep their rejects.
     
  5. anonymous

    anonymous Guest

    All are welcome
     
  6. anonymous

    anonymous Guest

    Many considered, few chosen.
     
  7. anonymous

    anonymous Guest

    Cindy can write her own ticket. She’s a hot commodity in high demand. Quest won’t make the mistake of letting her leave again.
     
  8. anonymous

    anonymous Guest

    You Questees are so pathetic. Buying us will never happen. Keep whining about our shady deals and I will keep counting my money.
     
  9. anonymous

    anonymous Guest

    Delusional. We will own BioReference before Christmas and guys like this won’t even get to try out for Team Quest.